I am Myung-Ju Ahn, M.D. who will be supposed to serve as Chairman of the Board of Directors of the Korean Association of Lung Cancer from 2023 to 2024. First of all, I wish you all members have peace and happiness all year round.
Lung cancer is the most common cause of cancer death worldwide including Korea. During the last two decades, with understanding of lung cancer biology, tremendous advances have been made in lung cancer including screening, diagnosis, surgery, radiotherapy, targeted therapy and immunotherapy. KALC is one of the leading representative academic associations which pursuits "the best healthcare for lung cancer" through "multidisciplinary approach", where many different areas of academia are involved such as radiology, pathology, pulmonology, surgery, radiation oncology, medical oncology, and nuclear medicine. Despite lots of challenges during COVID pandemic, KALC have been making efforts to improve lung cancer treatment and to conduct research, resulting in successful domestic and international conference. Moreover, KALC also made efforts to run several programs to have network with patients, such as "Ask anything about lung cancer" and "Lung cancer Day Event". For young KALC members, new education program "workshop for young doctors" was launched and will be expanded to the young doctors in Asia-Pacific regions as "international young doctor workshop".
I hope KALC will be the most exemplary and recognized academic association not only domestic but globally which provides the best healthcare for lung cancer through multi-disciplinary approach. I would like to ask all the members for continued support and corporation. Together with the President of KALC and other board members, I will do my best to improve harmony and communication among members, to balance among multidisciplinary area, and to support research activity.
I wish you all have good health and your wishes come true all year round.